Lupin launches triple combination inhaler for COPD in India

Drug maker Lupin Ltd announced the launch of Formoflo-G MDI, a fixed-dose triple combination metered-dose inhaler for the management of chronic obstructive pulmonary disease (COPD) in India, following approval from the Drug Controller General of India (DCGI).